Select pharma stocks gain amid neutral outlook for sector

20 Mar 2024 Evaluate

Select pharma stocks were trading higher on the BSE, as maintaining a neutral outlook for the pharmaceuticals sector for FY25, credit rating agency, India Ratings and Research (Ind-Ra) in its latest report is expecting pharmaceuticals companies to continue to benefit from growth in the domestic as well as export markets, while maintaining healthy EBITDA margins led by a moderation in the price erosion in the US generics business, softening of input costs, and high-value product launches in the US generic market. 

Aurobindo Pharma is currently trading at Rs. 1012.15, up by 22.75 points or 2.30% from its previous closing of Rs. 989.40 on the BSE.

Alembic Pharmaceuticals is currently trading at Rs. 949.10, up by 14.75 points or 1.58% from its previous closing of Rs. 934.35 on the BSE.

Glenmark Pharmaceuticals is currently trading at Rs. 928.65, up by 9.20 points or 1.00% from its previous closing of Rs. 919.45 on the BSE.

According to report named ‘FY25 Pharmaceuticals Outlook: Moving Up the Value Chain; Sustainable Margins in Sight’, the Indian pharmaceuticals market (IPM) is likely to grow 8%-9% year on year (yoy) in FY25 (FY24: 6%-7% yoy; FY23: 9.3% yoy). It further expects its US-focused pharma issuers to remain stable or report mid-to single-digit revenue growth in FY25 (FY23: 7.2% yoy; 9MFY24: 18.5% yoy) on account of lack of revenue from one-off products. Hence, the overall proportion of sales from the US is likely to remain stable. 

The report further noted that the active pharmaceuticals ingredients (API) business of Ind-Ra selected companies is expected to report high single-digit growth in FY25 due to a demand uptick. The overall revenue growth for them is also expected at around 9% yoy while maintaining healthy EBITDA margin performance (around 22%) in FY25. It also said that there has recently been a wave of M&A activity in the domestic formulations space, which is likely to continue.

Alembic Pharma Share Price

762.55 -6.00 (-0.78%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×